Palmitoylethanolamide/Luteolin as Adjuvant Therapy to Improve an Unusual Case of Camptocormia in a Patient with Parkinson ’s Disease: A Case Report
by Stefania Brotini, MD Dr. Brotini is with the Movement Disorder Center, Department of Neurology, San Giuseppe Hospital in Empoli, Florence, Italy FUNDING: No funding was provided for this study. DISCLOSURES: The author has no conflicts of interest relevant to the content of this article. Innov Clin Neurosci. 2021;18(10–12):12–14. ABSTRACT: Background. Camptocormia is a complication in […]
The post Palmitoylethanolamide/Luteolin as Adjuvant Therapy to Improve an Unusual Case of Camptocormia in a Patient with Parkinson’s Disease: A Case Report appeared first on Innovations in Clinical Neuroscience.
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: ICNS Online Editor Tags: Case Report Current Issue Neurodegenerative Disease Neurology Parkinson's disease adjuvant therapy camptocormia neurodegeneration neuromuscular complications Parkinson's disease (PD) ultra-micronized palmitoylethanolamide/luteolin Source Type: research
More News: Brain | Funding | Hospitals | Italy Health | Neurology | Neuroscience | Parkinson's Disease | Study